Moreover, the liposomal encapsulation of IL-2 has also been demonstrated to improve its therapeutic effectiveness in treating diseases such as cancer and acquired immunodeficiency syndrome by extending its half-life and minimizing related side effects [124]. The gene discussed is IL2; the disease is cancer.